 |
|
 |
 |

Home > Company Index > Drugs > Biotechnology-Medicine > Integra LifeSciences Holdings Corporation
 |
Integra LifeSciences Holdings Corporation |
 |
 |
 |
PROFILE |
 |
Integra LifeSciences still works in the skin trade, but has become more cerebral. The firm develops biomaterials for regenerating human tissue. In addition, Integra has branched into neuroscience, providing instruments, implants, and monitors for neurosurgery (about 65% of sales). Its Dermal Regenerative Template replaces skin and reduces the need for conventional grafts. The firm also sells products for infection control, dental surgery, and wound care. Integra LifeSciences sells products directly and through marketing relationships with units of such firms as Johnson & Johnson and Sulzer Medica. Chairman Richard Caruso owns about 40% of the company; investor George Soros controls about 15%.
COMPETITION |
 |
Advanced Tissue Sciences, Inc. (ATIS)
Johnson & Johnson (JNJ)
Medtronic, Inc. (MDT)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 65.00
1-Yr. Sales Growth: 52.9%
Employees: 515
Revenue per employee: $126,213.59
KEY PEOPLE |
 |
Stuart M. Essig
CEO
David B. Holtz
CFO
CONTACT INFO |
 |
311C Enterprise Dr.
Plainsboro, NJ 08536
US
Phone: 609-275-0500
Fax: 609-799-3297
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |